Hypertrophy
Sotagliflozin reduces CV risk in patients with LV hypertrophy without high BP
Patients with left ventricular hypertrophy without hypertension were at increased risk for CV death and HF events compared with the overall SCORED trial cohort, and sotagliflozin effectively reduced risk vs. placebo, a speaker reported.
Blood flow-restricted exercise may counteract age-related muscle decay
Published results showed low-load blood flow-restricted resistance exercise may stimulate skeletal muscle growth, improve muscle function and counteract muscle decay in older adults.
Older man presents with unilateral choroidal lesion
A 74-year-old white man presented as a referral to Lahey Hospital department of ophthalmology for a choroidal lesion of his left eye. He reported a progressive decline in his left eye vision for a year accompanied by intermittent floaters.
Intensive BP lowering reduces CV events in patients with hypertension, LV hypertrophy
In a cohort of patients with hypertension and left ventricular hypertrophy, those who achieved systolic BP < 130 mm Hg and diastolic BP < 80 mm Hg demonstrated the lowest risk for CVD events, according to new results.
Part of the Healio Network
Aortic Stenosis Topic Review
Aortic stenosis occurs when the orifice of the aortic valve is significantly reduced due to the failure of the aortic valve leaflets to open fully during systole.
Part of the Healio Network
Left Ventricular Hypertrophy (LVH) ECG Review
Left ventricular hypertrophy can be diagnosed on ECG with good specificity.